VEGFA and central nervous system cancer: Similar normalization of tumor blood vessels and a decreased tumor blood volume, resulting in prolonged survival, was observed in experimental animal models of brain metastases and glioma upon the treatment with cediranib or bevacizumab, an anti-VEGF antibody [42,164,165].